Indicators | Control group | Intervention group | Treatment effecta | |||||
---|---|---|---|---|---|---|---|---|
 | Pre | Post | Pre | Post | Unadjusted (95% CI) | P | Adjusted (95% CI) | P |
Percentage of prescriptions requiring IV injection (%) | ||||||||
All | 90.00 | 86.17 | 81.82 | 77.89 | 1.66 (-5.50, 8.83) | 0.649 | 1.23 (-3.82, 6.28) | 0.633 |
Male | 90.01 | 85.75 | 82.29 | 78.30 | 2.05 (-5.77, 9.86) | 0.608 | 1.36 (-4.68, 7.39) | 0.659 |
Female | 89.97 | 86.62 | 81.34 | 77.49 | 1.22 (-5.62, 8.08) | 0.725 | 1.22 (-3.18, 5.62) | 0.587 |
Percentage of prescriptions requiring infusion (%) | ||||||||
All | 89.76 | 85.87 | 81.45 | 77.64 | 1.82 (-5.59, 9.23) | 0.630 | 1.37 (-3.93, 6.67) | 0.612 |
Male | 89.81 | 85.39 | 81.83 | 78.02 | 2.38 (-5.52, 10.27) | 0.555 | 1.72 (-4.32, 7.76) | 0.577 |
Female | 89.71 | 86.39 | 81.06 | 77.28 | 1.20 (-6.00, 8.41) | 0.743 | 1.14 (-3.73, 6.02) | 0.645 |
Average expenditure per prescription (Â¥ Yuan) | ||||||||
All | 27.53 | 41.21 | 29.72 | 37.82 | -12.80 (-41.77, 16.17) | 0.363 | -1.21 (-16.33, 13.90) | 0.867 |
Male | 27.60 | 40.38 | 29.39 | 37.74 | -10.10 (-38.04, 17.85) | 0.455 | 0.60 (-14.37, 15.57) | 0.933 |
Female | 27.46 | 42.09 | 30.06 | 37.89 | -15.64 (-45.97, 14.69) | 0.290 | -3.00 (-18.76, 12.77) | 0.692 |